Systemic lupus erythematosus (SLE) is a multisystemic inflammatory autoimmune disorder. Thrombotic events occur at a higher incidence among SLE patients. The investigation of thrombin generation (TG) with calibrated automated thrombogram (CAT) test as a global hemostasis assay is applicable for the overall functional assessment of the hemostasis. The aim of this study was to characterize the hemostatic alterations observed in SLE by CAT assay. In this study, CAT parameters and basic coagulation parameters of SLE patients (n = 22) and healthy control subjects (n = 34) were compared. CAT area under the curve (i.e., endogenous thrombin potential) was lower than normal in SLE (807 vs. 1,159 nM*min, respectively), whereas other CAT parameters (peak, lag time, time to peak, and velocity index) and the basic coagulation tests were within the normal range. The presence of anti-phospholipid antibodies and the applied therapy was not associated with hemostasis parameters in SLE. We concluded that the reported high risk of thrombosis is not related to TG potential.
Boeer K , Cuznetov L , Loesche W : Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics. Thromb. J. 11, 24 (2013)
Burgos PI , Alarcón GS : Thrombosis in systemic lupus erythematosus: risk and protection. Expert Rev. Cardiovasc. Ther. 7, 1541–1549 (2009)
Calvo-Alen J , Toloza SMA , Fernandez M , Barri HM , Fessler J , Roseman JM , McGwin G , Vila LM , Reveille JD , Alarcon GS , LUMINA Study Group: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA), XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum. 52, 2060–2068 (2005)
Cervera R , Khamashta MA , Font J , Sebastiani GD , Gil A , Lavilla P , Mejía JC , Aydintug AO , Chwalinska-Sadowska H , de Ramón E , Fernández-Nebro A , Galeazzi M , Valen M , Mathieu A , Houssiau F , Caro N , Alba P , Ramos-Casals M , Ingelmo M , Hughes GRV , European Working Party on Systemic Lupus Erythematosus: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82, 299–308 (2003)
Chung WS , Lin CL , Chang SN , Lu CC , Kao CH : Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study. J. Thromb. Haemost. 12, 452–458 (2014)
Devreese K , Peerlinck K , Arnout J , Hoylaerts MF : Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography. Thromb. Haemost. 101, 185–196 (2009)
Ferro D , Quintarelli C , Valesini G , Violi F : Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus [letter; comment]. Blood 83, 304 (1994)
Ginsberg JS , Demers C , Brill-Edwards P , Johnston M , Bona R , Burrows RF , Weitz J , Denburg JA : Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood 81, 2958–2963 (1993)
Gustafsson JT , Gunnarsson I , Källberg H , Pettersson S , Zickert A , Vikerfors A , Möller S , Rönnelid J , Elvin K , Svenungsson E : Cigarette smoking, antiphospholipid antibodies and vascular events in systemic lupus erythematosus. Ann. Rheum. Dis. 74, 1537–1543 (2015)
Hemker HC , Al Dieri R , De Smedt E : Thrombin generation, a function test of the haemostatic-thrombotic system. J. Thromb. Haemost. 96, 553–561 (2006)
Kluft C , Meijer P : External quality assessment for thrombin generation tests: an exploration. Semin. Thromb. Hemost. 36, 791–796 (2010)
Liestøl S , Sandset PM , Jacobsen EM , Movinckel MC , Wisløff F : Decreased anticoagulant response to tissue factor pathway inhibitor type 1 plasmas from patients with lupus anticoagulants. Br. J. Haematol. 136, 131–137 (2006)
Liestøl S , Sandset PM , Mowinckel MC , Wisløff F : Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. J. Thromb. Haemost. 5, 2204–2210 (2007)
Meesters EW , Hansen H , Spronk HMH , Hamulyak K , Rosing J , Rowshani AT , ten Berge IJM , ten Cate H : The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul. Fibrinolysis 18, 21–28 (2007)
Ninivaggi M , Klechtermans H , Lindhout T , de Laat B : Conformation of beta2glycoprotein I and its effect on coagulation. Thromb. Res. 130, S33–S36 (2012)
Panova-Noeva M , Marchetti M , Spronk HM , Russo L , Diani E , Finazzi G , Salmoiraghi S , Rambaldi A , Barbui T , Ten Cate H , Falanga A : Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera. Am. J. Hematol. 86, 337–342 (2011)
Pereira J , Alfaro G , Goycoolea M , Quiroga T , Ocqueteau M , Massardo L , Pérez C , Sáez C , Panes O , Matus V , Mezzano D : Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb. Haemost. 95, 94–99 (2006)
Petri M : Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort. Lupus 19, 419–423 (2010)
Regnault V , Béguin S , Wahl D , de Maistre E , Hemker HC , Lecompte T : Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thromb. Haemost. 89, 208–212 (2003)
Somers E , Magder LS , Petri M : Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J. Rheumatol. 12, 2531–2536 (2002)
Tripodi A , Legnani C , Chantarangkul V , Cosmi B , Palareti G , Mannucci PM : High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J. Thromb. Haemost. 6, 1327–1333 (2008)
Zuily S , Ait Aissa K , Membre A , Regnault V , Lecompte T , Wahl D : Thrombin generation in antiphospholipid syndrome. Lupus 21, 758–760 (2012)